Bellicum
focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders... Read moreBellicum
focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders... Read more
2004
PublicNASDAQBLCM
News
Feb 26, 2024
Pulse2.0
Bellicum: MD Anderson Acquiring Inducible Switch Technologies: Details
Dec 14, 2023
MarketScreener
Bellicum: Bellicum Pharmaceuticals : 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 - Form 8-K
Nov 15, 2023
Owler
Bellicum Pharmaceuticals, Inc.: Bellicum's revenue changed from $6.71M in Mar 2023 to $7.01M in Sep 2023
Nov 15, 2023
Yahoo
Bellicum: Bellicum Pharmaceuticals: Q3 Earnings Snapshot
Aug 21, 2023
MarketScreener
Bellicum: Bellicum Pharmaceuticals : Regulation FD Disclosure - Form 8-K
Aug 11, 2023
Yahoo
Bellicum: Bellicum Pharmaceuticals: Q2 Earnings Snapshot
May 12, 2023
Owler
Bellicum Pharmaceuticals, Inc.: Bellicum's revenue had no change from Dec 2022 to Mar 2023
Apr 03, 2023
Owler
Bellicum Pharmaceuticals, Inc.: Bellicum's employee count changed from 7 in Dec 2021 to 13 in Dec 2022
Mar 15, 2023
Endpoints News
Bellicum: Bellicum halts trials after serious adverse event, looks for 'strategic alternatives'
Mar 15, 2023
Benzinga
Bellicum: Bellicum Pharmaceuticals shares are trading lower after the company discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
Bellicum Competitors
1
2
3
4
5
6
7
8
9
10